What is Actos?
Actos Warnings and Alerts
Actos Smoking Gun
Actos Lawsuits
Actos Whistleblower Lawsuit
Our Actos Attorneys
Our Case Results
Contact an Actos Lawyer

Bladder Cancer Information
Bladder Cancer Types
Bladder Cancer Symptoms
Bladder Cancer Treatment
Bladder Cancer Causes

Studies Link Actos to
Bladder Cancer

Medical Terms Dictionary

Report Adverse Side Effects
to FDA MedWatch

Report Adverse Side Effects
to Rxisk.org

Watch Our Video

Tell Us What
Happened to You

*Confirm Email
This field must be blank
*Describe your symptoms
Recent News

Actos Bladder Cancer Lawsuit Verdict Reinstated
July 16, 2015

Takeda Pharmaceuticals Continues Court Ordered Search for Missing Files in Actos Bladder Cancer Litigation
October 17, 2014
Takeda and Eli Lilly Sued Over Actos Bladder Cancer Claims
September 5, 2014

We are no longer accepting Actos cases.

Our Actos Bladder Cancer Attorneys

If you took Actos and you were later diagnosed with bladder cancer, you may be entitled to compensation. It is imperative that you contact an experienced law firm to guide you through the complicated process of filing a claim.

Baum, Hedlund, Aristei & Goldman’s pharmaceutical drug defect attorneys are investigating Actos bladder cancer cases for diabetes patients throughout the United States. Our firm has successfully represented clients harmed by medications in over 4,000 individual cases, in addition to representing consumers in multiple pharmaceutical class actions.

We have represented thousands of people across the nation who have been harmed by a prescription medications. We are currently representing diabetes patients who have bladder cancer after taking Actos.

The team of lawyers working on the Actos bladder cancer cases have an in depth understanding of biomedical research, clinical trials, statistics, the pharmaceutical industry and marketing, as well as successful and effective discovery procedures and extensive work with experts on complicated scientific issues because of their years of experience related to Baum Hedlund’s past pharmaceutical litigation.

Michael L. Baum

Ronald L.M. Goldman

Frances M. Phares

Our attorneys have over 25 years experience litigating product liability cases against major pharmaceutical manufacturers. While representing our clients, we dig deep into drug company files to discover the truth about what the company knew about the drug’s risks, when the company knew of those risks and what efforts, if any, the company took to hide those risks. Only through legal action can anyone gain access to this type of information.

The senior attorneys of our law firm, themselves, prepare and direct all cases and the firm’s attorneys work as a team and collaborate on each case.  Our firm has filed dozens of Actos bladder cancer lawsuits in state court in California and federal court in Louisiana, where all of the federally filed cases are being consolidated in preparation for the trial against Takeda and Eli Lilly.  We are also preparing for trial at the state level in California.

Senior partner, Michael Baum, has been appointed to the Plaintiffs' Steering Committee (PSC), Judicial Council Coordinated Proceedings (JCCP 4696) In re Actos Product Liability Cases in Los Angeles, California.  The members of the PSC manage the complex mass tort litigation arising from the Actos bladder cancer cases that have been consolidated in California at Los Angeles Superior Court.

Michael is also working directly with the PSC overseeing the Actos MDL 6:11-md-2299 (multi-district litigation) cases consolidated in federal court in the United States District Court for the Western District of Louisiana, specifically working within the Science Committee.

We have developed a reputation as a law firm that can be counted upon to go above and beyond what is needed to get the job done; a firm that has successfully litigated personal injury, wrongful death and consumer fraud cases against major pharmaceutical companies such as Alpha Therapeutic, Armour Pharmaceutical Co., Baxter Health Care Corp, Bayer Corp., Dalkon Corporation, Eli Lilly, GlaxoSmithKline, and Pfizer.

Our lawyers are also strong public health advocates. Baum Hedlund attorneys have testified on several occasions at FDA drug safety hearings and have met with several members of the U.S. House and Senate. Many of our attorneys have delivered Continuing Legal Education accredited lectures and written articles on the many complex issues involved in pharmaceutical litigation. Our law firm has also assisted investigators in a number of Congressional investigations.

We take pride in creating coalitions of activists, attorneys and Baum Hedlund staff that work together to resolve global problems caused by harmful drugs and products, which no individual could accomplish alone.

Rigorously investigating and litigating the types of devastating cases we handle on a daily basis requires relentless focus and dedication to our clients’ causes. We are tenacious and unflinching when it comes to seeking evidence and have routinely prevailed in both state and federal courts.

Give us a call today at 800-827-0087 or email us so we can ensure you get the representation you and your family deserve.